American Society of Addiciton Medicine
Dec 1, 2025 Reporting from Rockville, MD
ASAM Statement on Passage of the SUPPORT Reauthorization Act
https://www.asam.org/news/detail/2025/12/01/asam-statement-on-passage-of-the-support-reauthorization-act
Dec 1, 2025

ASAM Statement on Passage of the SUPPORT Reauthorization Act.Substring(0, maxlength)

American Society of Addictin Medicine

News

ASAM Statement on Passage of the SUPPORT Reauthorization Act

Congress’ reauthorization of SUPPORT is a needed step to address America’s addiction crisis, but the administration’s weakening of SAMHSA casts doubts on if this funding will reach addiction treatment clinicians on the frontlines 

Further legislation is also needed to expand and strengthen addiction care 

Rockville, MD (Dec. 1, 2025) - In response to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) being signed into law, Stephen M. Taylor, MD, MPH, DFAPA, DFASAM, president of the American Society of Addiction Medicine (ASAM), issued the following statement: 

“The SUPPORT Reauthorization Act contains several critical provisions to bolster America’s response to the addiction and overdose crisis. It reauthorizes the Health Resources and Services Administration’s (HRSA) Substance Use Disorder Treatment and Recovery Loan Repayment Program (STAR-LRP) and the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Comprehensive Opioid Recovery Centers grant program, and it expands SAMHSA’s Minority Fellowship Program to include physicians who specialize in addiction medicine.

However, reductions in expert staff at SAMHSA invite legitimate concerns over how, and when, provisions within SUPPORT will reach addiction medicine clinicians. These programs risk being reauthorized in name only if SAMHSA is not fully equipped to administer them.  

And let’s be clear: this bill alone is not a cure-all for America’s addiction and overdose crisis. Persistent Medicare coverage gaps and outdated prescribing restrictions on methadone for opioid use disorder (OUD) still make it challenging for addiction specialist physicians to deliver quality addiction care to Americans in need.

ASAM continues to urge Congress to pass the Modernizing Opioid Treatment Access Act (MOTAA), which would allow addiction specialist physicians to prescribe methadone for OUD and have it dispensed from community pharmacies. Methadone is highly effective in treating patients with OUD involving fentanyl, yet red tape prevents addiction specialists from prescribing this FDA-approved medication.

In addition, seniors struggling with addiction still lack Medicare coverage for 24-hour residential care, which may be the best fit for some. Passing the Residential Recovery for Seniors Act (RRSA) would close this dangerous coverage gap.

Addiction specialists are confronting an unpredictable illicit drug supply without full access to the treatment tools that can prevent overdose and save lives. Congress must show that it’s truly committed to protecting the health of Americans by passing MOTAA and RRSA.” 

 

# # #

 

About the American Society of Addiction Medicine    

The American Society of Addiction Medicine (ASAM), founded in 1954, is a professional medical society representing over 8,000 physicians, clinicians, and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction. For more information, visit www.ASAM.org.   


 

Media Contact

Sarah Shelson

301-547-4110 

sshelson@ASAM.org

 

Tags:

Related Articles